Company / Operating Income
Arcus Biosciences, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$386.0M
FY2025
5-year range
-$386.0M / $54.0M
FY2021-FY2025
Trend
-17.0%
vs FY2024
Sector context
#178 of 204
Health Care
What the data says
Arcus Biosciences, Inc.'s operating income of -$386M is lower than 87% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from -$386M in FY2025 to $54M in FY2021.
Based on SEC 10-K filings.
-$386M in FY2025.
Declined from -$340M to -$386M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 204This company -$386.0M Sector average $107.7M
▼
-458.3% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 17.0% year-over-year.
- Ranks #178 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$386.0M | -17.0% |
| FY2024 | -$330.0M | +2.9% |
| FY2023 | -$340.0M | -174.2% |
| FY2022 | -$124.0M | -329.6% |
| FY2021 | $54.0M | +198.4% |
| FY2020 | -$54.9M | +38.2% |
| FY2019 | -$88.7M | -387.9% |
| FY2018 | -$18.2M | +66.0% |
| FY2017 | -$53.4M | -193.9% |
| FY2016 | -$18.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026